Equillium Inc (EQ)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $106.20M
Last updated: Nov 17, 2026 at 11:05 AM ET
Equillium Inc (EQ) Stock Forecast
Analysts expect Equillium (EQ) to earn -$0.21 per share in the fiscal year ending Dec 31, 2026. Of 9 analysts, 9 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 4 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 9 ratings average 1.89, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 11.1% |
| Buy | 8 | 88.9% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 9
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss.
- Fiscal year ending Dec 31, 2026
- -$0.21
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.24
- EPS consensus
- Next report
- Mar 23, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.21 | -$0.22 to -$0.17 | 7 |
| Dec 31, 2027 | -$0.24 | -$0.36 to -$0.15 | 7 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.06 | -$0.07 to -$0.03 | 13 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 4 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 4 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.24.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.21 | -$0.21 | -$0.21 | -$0.21 | -$0.24 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.24 | -$0.24 | -$0.23 | -$0.23 | -$0.27 | N/A |
Frequently Asked Questions About EQ
What is the EQ stock forecast?
Consensus analyst estimates put Equillium's EPS at -$0.21 for the fiscal year ending Dec 31, 2026. The consensus rating from 9 analysts is Buy.
How do analysts rate EQ stock?
Of 9 analysts covering Equillium, 1 rates it Strong Buy, 8 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from EQ next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.21, with estimates from -$0.22 to -$0.17 from 7 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.24, with estimates from -$0.36 to -$0.15 from 7 analysts.
How many analysts cover EQ?
9 analysts rate Equillium stock, and 7 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
EQ pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors